首页> 外文会议>Pacific Symposium on Biocomputing; 20080104-08; Kohala Coast,HI(US) >MINING METABOLIC NETWORKS FOR OPTIMAL DRUG TARGETS
【24h】

MINING METABOLIC NETWORKS FOR OPTIMAL DRUG TARGETS

机译:用于最佳药物目标的挖掘代谢网络

获取原文
获取原文并翻译 | 示例

摘要

Recent advances in bioinformatics promote drug-design methods that aim to reduce side-effects. Efficient computational methods are required to identify the optimal enzyme-combination (i.e., drug targets) whose inhibition, will achieve the required effect of eliminating a given target set of compounds, while incurring minimal side-effects. We formulate the optimal enzyme-combination identification problem as an optimization problem on metabolic networks. We define a graph based computational damage model that encapsulates the impact of enzymes onto compounds in metabolic networks. We develop a branch-and-bound algorithm, named OPMET, to explore the search space dynamically. We also develop two filtering strategies to prune the search space while still guaranteeing an optimal solution. They compute an upper bound to the number of target compounds eliminated and a lower bound to the side-effect respectively. Our experiments on the human metabolic network demonstrate that the proposed algorithm can accurately identify the target enzymes for known successful drugs in the literature. Our experiments also show that OPMET can reduce the total search time by several orders of magnitude as compared to the exhaustive search.
机译:生物信息学的最新进展促进了旨在减少副作用的药物设计方法。需要有效的计算方法来鉴定最佳的酶组合(即药物靶标),其抑制作用将达到消除给定靶标化合物组所需的效果,同时产生最小的副作用。我们将最佳酶组合识别问题公式化为对代谢网络的优化问题。我们定义了一个基于图的计算损伤模型,该模型封装了酶对代谢网络中化合物的影响。我们开发了一种称为OPMET的分支定界算法,以动态地探索搜索空间。我们还开发了两种过滤策略来修剪搜索空间,同时仍保证最佳解决方案。他们分别计算出消除的目标化合物数量的上限和副作用的下限。我们在人体代谢网络上的实验表明,所提出的算法可以准确地识别文献中已知成功药物的靶酶。我们的实验还表明,与详尽搜索相比,OPMET可以将总搜索时间减少几个数量级。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号